STOCKHOLM--(BUSINESS WIRE)--Nanologica AB today announced that the Company is a key player in the ORCHID project. The ORCHID alliance brings together tuberculosis (TB) expertise from academia, government research centres, non-profit organizations and biotech companies. The project is funded by European Union’s Seventh Framework Programme.
